default author photo

Mary Falzon

University College London Hospital - Department of Cellular Pathology

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

170

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Initial Outcome of the TARGIT-B International Randomised Trial of Targeted Intraoperative Radiotherapy Tumour Bed Boost for Young or High-Risk Patients with Breast Cancer

Number of pages: 22 Posted: 27 Feb 2026
University College London - Division of Surgery and Interventional Science, University of Notre Dame Australia - Institute for Health Research, University College London Hospitals - Department of Clinical Oncology, University College London - Division of Surgery and Interventional Science, University College London - Division of Medicine, Yonsei University - Gangnam Severance Hospital, Gauteng Netcare Milpark Hospital, Gauteng Netcare Milpark Hospital, Centro di Riferimento Oncologico, Centro di Riferimento Oncologico, University Malaya Medical Centre, University Malaya Medical Centre, Universidad Fernando Pessoa Canarias, Hospitales Universitarios San Roque, Universidad Fernando Pessoa Canarias, Veneto Institute of Oncology IOV - IRCCS, Veneto Institute of Oncology IOV - IRCCS, Centre Georges-Francois Leclerc, Whittington Hospital, University College London Hospital - Department of Cellular Pathology, Imam Abdulrahman Bin Faisal University, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Institut Català d'Oncologia, Government of the United Kingdom - Great Western Hospitals, Government of the United Kingdom - Great Western Hospitals, Princess Alexandra Hospital, Princess Alexandra Hospital, Princess Alexandra Hospital, Princess Alexandra Hospital, Princess Alexandra Hospital, IUCT Oncopole - Institut Universitaire du Cancer de Toulouse, Institut de Cancerologie de l’Ouest, Institut de Cancerologie de l’Ouest, Bergonié Institute, Bergonié Institute, Government of the United Kingdom - Royal Free London NHS Foundation Trust, Chulalongkorn University - King Chulalongkorn Memorial Hospital, Chulalongkorn University - King Chulalongkorn Memorial Hospital, Chulalongkorn University - King Chulalongkorn Memorial Hospital, Beijing Cancer Hospital, Beijing Cancer Hospital, Beijing Cancer Hospital, Northwell Health, Centre François Baclesse, Legacy Good Samaritan Medical Center, Guy's Hospital, Helen Rey Breast Cancer Research Foundation, Royal Hampshire County Hospital, Royal Hampshire County Hospital, Lakeland Health, NHS Lothian - St John’s Hospital, Aurora Baycare Medical Cente, Aurora Baycare Medical Cente, Aix-Marseille University, Aix-Marseille University, Aix-Marseille University, Brust-Zentrum Seefeld, Brust-Zentrum Seefeld, West Virginia University - West Virginia University Health Sciences Center, William Beaumont Hospital, William Beaumont Hospital, Centre Léon Berard, Memorial University Medical Center, Cleveland Clinic, University College London, University College London, Russell Investment Group (London), University College London and University of Oxford
Downloads 103 (725,554)

Abstract:

Loading...

breast cancer, radiotherapy, intraoperative radiotherapy, lumpectomy, wide local excision, breast conserving surgery, TARGIT-IORT, survival from breast cancer

2.

Determinants of Anti-PD1 Response and Resistance in Clear Cell Renal Cell Carcinoma

Number of pages: 64 Posted: 26 Mar 2021
The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Retroviral Immunology, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Cancer Dynamics Laboratory, University College London - Cancer Immunology Unit, The Francis Crick Institute, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Francis Crick Institute - Cancer Dynamics Laboratory, Francis Crick Institute - Cancer Dynamics Laboratory, Royal Marsden NHS Foundation Trust - Renal and Skin Units, Francis Crick Institute - Retroviral Immunology, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Biocruces Bizkaia Health Research Institute - Department of Pathology, Guy's and St Thomas' NHS Foundation Trust - Department of Cellular Pathology, Guy's and St Thomas' NHS Foundation Trust - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Cancer Institute - Cancer Research UK Lung Cancer Centre of Excellence, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, Royal Marsden NHS Foundation Trust - Renal and Skin Units, Royal Marsden NHS Foundation Trust - Renal and Skin Units, University College London - Cancer Immunology Unit, Peter MacCallum Cancer Centre - Division of Research, University College London Hospital - Department of Cellular Pathology, University College London - Cancer Research UK Lung Cancer Centre of Excellence, Independent, The Francis Crick Institute, University College London - Division of Infection and Immunity, Royal Marsden NHS Foundation Trust - Renal and Skin Units, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory and Independent
Downloads 67 (899,324)
Citation 1

Abstract:

Loading...

clear cell renal cell carcinoma, nivolumab, immunotherapy, cytotoxicity, TCR clonal maintenance, TCR clonal replacement, human endogenous retrovirus, longitudinal sampling, multiregion sampling, autopsy